Desmoid tumor of lower extremity and pelvic girdle
ICD-10 D48.116 is a billable code used to indicate a diagnosis of desmoid tumor of lower extremity and pelvic girdle.
Desmoid tumors, also known as aggressive fibromatosis, are benign neoplasms that arise from the connective tissue and are characterized by their infiltrative growth pattern. They can occur in various locations, including the lower extremity and pelvic girdle. These tumors are classified as neoplasms of uncertain behavior, meaning they do not metastasize but can exhibit local aggressiveness, leading to significant morbidity. Clinically, desmoid tumors may present as painless masses, but they can cause discomfort or functional impairment depending on their size and location. Surveillance is crucial as these tumors can recur after surgical excision, and their behavior can change over time. The management of desmoid tumors often involves a multidisciplinary approach, including surgical intervention, observation, and sometimes pharmacological treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or hormonal therapy. Regular follow-up is essential to monitor for recurrence or progression, as these tumors can be unpredictable in their behavior.
Detailed pathology reports, imaging studies, and treatment plans.
Initial diagnosis, treatment planning, and follow-up for recurrence.
Ensure accurate staging and grading of the tumor.
Surgical reports, post-operative follow-up notes, and imaging results.
Surgical excision of the tumor and management of complications.
Document the extent of resection and any adjuvant therapies.
Used when excising a desmoid tumor from the lower extremity.
Operative report detailing the excision and margins.
Orthopedic surgeons should document the extent of resection.
The prognosis for patients with desmoid tumors varies. While they are benign and do not metastasize, they can be locally aggressive and may recur after treatment. Regular surveillance is important to monitor for changes.
